August 2021

  • NPAC responded to Food and Drug Administration’s (FDA) request for comments related to its summit on Morphine Milligram Equivalents.

  • NPAC solicited commentary in Colorado on its PDMP audit, and provided solicited testimony during hearings in the Colorado legislature. 

Previous
Previous

September 2021

Next
Next

July 2021